Wolfe Research Initiates Coverage On Taysha Gene Therapies with Outperform Rating

Benzinga Newsdesk www.benzinga.com Positive 78.6%

Neg 0% Neu 0% Pos 78.6%

Wolfe Research analyst Kalpit Patel initiates coverage on Taysha Gene Therapies (NASDAQ:TSHA) with a Outperform rating.

Comments

No comments yet. Be the first!